Detection of High-Risk Human Papillomavirus DNA in Invasive Ductal Carcinoma Specimens

Overview

Journal Asian Pac J Cancer Prev

Specialty Oncology

Date 2022 Sep 29

PMID 36172685

Authors

Mastaneh Alinezhadi

Manoochehr Makvandi

Gholam Abbas Kaydani

Seyed Nematollah Jazayeri

Javad Charostad

Abdolhassan Talaiezadeh Talaeizadeh

Kambiz Ahmadi Angali

Affiliations

Soon will be listed here.

Abstract

Background: According to several studies, there is an association between human papillomavirus (HPV) and breast cancer. Therefore, detection and genotyping of HPV seem important. The present study aimed to investigate the presence of HPV DNA in breast tissues by analyzing the L1 gene.

Materials And Methods: This case-control study was conducted on 63 formalin-fixed paraffin-embedded (FFPE) tissues of invasive ductal carcinoma (IDC) as the case group and 32 FFPE tissues of fibroadenoma as the control group. HPV DNA was detected using the polymerase chain reaction assay. Positive samples were then subjected to genotyping. All statistical analyses were performed in SPSS version 22.0.

Results: The patients' age ranged from 15 to 92 years, with a mean age of 43.54±16.36 years. HPV DNA was detected in 17/95 (17.89%) samples, including 9/32 (28.12%) fibroadenoma samples and 8/63 (12.69%) IDC samples. No significant difference was observed regarding the presence of HPV DNA between the IDC and fibroadenoma tissues (P=0.08). However, a significant difference was found in the detection of high-risk HPV (HR-HPV) between the case and control groups (P=0.03). In the case group, 87.5% of the detected viruses (7/8 samples) were HR-HPV, while in the control group, 22.22% of positive samples (2/9 samples) were HR-HPV (P=0.03). Based on the results, HR-HPV and low-risk HPV genotypes were detected in 53% (9/17) and 47% (8/17) of positive samples, respectively.

Conclusion: In this study, 12.69% of IDC samples were positive for HPV genomes, and HR-HPV was detected in 87.5% of these samples. The present results suggest the important role of HR-HPV in the development of breast cancer.

Citing Articles

Molecular Prevalence of Human Papillomavirus Types 16 and 18 in Oral Squamous Cell Carcinoma using Real-time PCR.

Azmoudeh F, Aslanimehr M, Alizadeh S, Sadeghi H, Zamanpoor S, Mokhlesi A Arch Razi Inst. 2024; 79(2):361-366.

PMID: 39463710 PMC: 11512172. DOI: 10.32592/ARI.2024.79.2.361.

The viral origins of breast cancer.

Lawson J, Glenn W Infect Agent Cancer. 2024; 19(1):39.

PMID: 39187871 PMC: 11346025. DOI: 10.1186/s13027-024-00595-2.

Unveiling the multifaceted realm of human papillomavirus: a comprehensive exploration of biology, interactions, and advances in cancer management.

Wu M, Huang H, Tang Y, Ren X, Jiang X, Tian M Front Immunol. 2024; 15:1430544.

PMID: 39176086 PMC: 11338918. DOI: 10.3389/fimmu.2024.1430544.

The association between infectious agents and breast cancer: a review of the epidemiologic evidence.

Brantley K, Tamimi R Breast Cancer Res Treat. 2024; 207(2):235-252.

PMID: 38971906 DOI: 10.1007/s10549-024-07388-6.

The Role of Oncogenic Viruses in the Pathogenesis of Sporadic Breast Cancer: A Comprehensive Review of the Current Literature.

Rossi C, Inzani F, Cesari S, Rizzo G, Paulli M, Pedrazzoli P Pathogens. 2024; 13(6).

PMID: 38921749 PMC: 11206847. DOI: 10.3390/pathogens13060451.

References

Bansal A, Singh M, Rai B . Human papillomavirus-associated cancers: A growing global problem. Int J Appl Basic Med Res. 2016; 6(2):84-9. PMC: 4830161. DOI: 10.4103/2229-516X.179027. View

de Cremoux P, Thioux M, Lebigot I, Sigal-Zafrani B, Salmon R, Sastre-Garau X . No evidence of human papillomavirus DNA sequences in invasive breast carcinoma. Breast Cancer Res Treat. 2007; 109(1):55-8. DOI: 10.1007/s10549-007-9626-4. View

Zhou Y, Li J, Ji Y, Ren M, Pang B, Chu M . Inconclusive role of human papillomavirus infection in breast cancer. Infect Agent Cancer. 2015; 10:36. PMC: 4620698. DOI: 10.1186/s13027-015-0029-6. View

Stanley M . Epithelial cell responses to infection with human papillomavirus. Clin Microbiol Rev. 2012; 25(2):215-22. PMC: 3346303. DOI: 10.1128/CMR.05028-11. View

Mou X, Chen L, Liu F, Shen Y, Wang H, Li Y . Low prevalence of human papillomavirus (HPV) in Chinese patients with breast cancer. J Int Med Res. 2011; 39(5):1636-44. DOI: 10.1177/147323001103900506. View

Tsai J, Tsai C, Cheng M, Lin S, Xu F, Yang C . Association of viral factors with non-familial breast cancer in Taiwan by comparison with non-cancerous, fibroadenoma, and thyroid tumor tissues. J Med Virol. 2004; 75(2):276-81. DOI: 10.1002/jmv.20267. View

Burd E . Human papillomavirus and cervical cancer. Clin Microbiol Rev. 2003; 16(1):1-17. PMC: 145302. DOI: 10.1128/CMR.16.1.1-17.2003. View

Moustafa A, Al-Antary N, Aboulkassim T, Akil N, Batist G, Yasmeen A . Co-prevalence of Epstein-Barr virus and high-risk human papillomaviruses in Syrian women with breast cancer. Hum Vaccin Immunother. 2016; 12(7):1936-9. PMC: 4964818. DOI: 10.1080/21645515.2016.1139255. View

Doosti M, Bakhshesh M, Zahir S, Shayestehpour M, Karimi-Zarchi M . Lack of Evidence for a Relationship between High Risk Human Papillomaviruses and Breast Cancer in Iranian Patients. Asian Pac J Cancer Prev. 2016; 17(9):4357-4361. View

10.

Braaten K, Laufer M . Human Papillomavirus (HPV), HPV-Related Disease, and the HPV Vaccine. Rev Obstet Gynecol. 2008; 1(1):2-10. PMC: 2492590. View

11.

Yim E, Park J . The role of HPV E6 and E7 oncoproteins in HPV-associated cervical carcinogenesis. Cancer Res Treat. 2009; 37(6):319-24. PMC: 2785934. DOI: 10.4143/crt.2005.37.6.319. View

12.

Mahmoudvand S, Safaei A, Erfani N, Sarvari J . Presence of Human Papillomavirus DNA in Colorectal Cancer Tissues in Shiraz, Southwest Iran. Asian Pac J Cancer Prev. 2015; 16(17):7883-7. DOI: 10.7314/apjcp.2015.16.17.7883. View

13.

Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M . Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 2014; 136(5):E359-86. DOI: 10.1002/ijc.29210. View

14.

Sigaroodi A, Nadji S, Naghshvar F, Nategh R, Emami H, Velayati A . Human papillomavirus is associated with breast cancer in the north part of Iran. ScientificWorldJournal. 2012; 2012:837191. PMC: 3329875. DOI: 10.1100/2012/837191. View

15.

Fernandes A, Bianchi G, Feltri A, Perez M, Correnti M . Presence of human papillomavirus in breast cancer and its association with prognostic factors. Ecancermedicalscience. 2015; 9:548. PMC: 4494820. DOI: 10.3332/ecancer.2015.548. View

16.

Abreu A, Souza R, Gimenes F, Consolaro M . A review of methods for detect human Papillomavirus infection. Virol J. 2012; 9:262. PMC: 3507852. DOI: 10.1186/1743-422X-9-262. View

17.

Bae J, Kim E . Human papillomavirus infection and risk of breast cancer: a meta-analysis of case-control studies. Infect Agent Cancer. 2016; 11:14. PMC: 4791894. DOI: 10.1186/s13027-016-0058-9. View

18.

Ahangar-Oskouee M, Shahmahmoodi S, Jalilvand S, Mahmoodi M, Ziaee A, Esmaeili H . No detection of 'high-risk' human papillomaviruses in a group of Iranian women with breast cancer. Asian Pac J Cancer Prev. 2014; 15(9):4061-5. DOI: 10.7314/apjcp.2014.15.9.4061. View

19.

Azubuike S, Muirhead C, Hayes L, McNally R . Rising global burden of breast cancer: the case of sub-Saharan Africa (with emphasis on Nigeria) and implications for regional development: a review. World J Surg Oncol. 2018; 16(1):63. PMC: 5863808. DOI: 10.1186/s12957-018-1345-2. View

20.

Ghaffari H, Nafissi N, Hashemi-Bahremani M, Alebouyeh M, Tavakoli A, Javanmard D . Molecular prevalence of human papillomavirus infection among Iranian women with breast cancer. Breast Dis. 2018; 37(4):207-213. DOI: 10.3233/BD-180333. View